|
|
||||||||
Ann Thorac Surg 1987;43:182-184
© 1987 The Society of Thoracic Surgeons
From the Thoracic Surgery Service, Walter Reed Army Medical Center, The Division of Surgery, Walter Reed Army Institute of Research, Washington, DC Department of Surgery, The Uniformed Services University of the Health Sciences, Bethesda, MD
Accepted for publication March 14, 1986.
* Address reprint requests to Dr. Graeber, Division of Surgery, Walter Reed Army Institute of Research, Washington, DC 20307-5100
Ventricular fibrillation during reperfusion after aortic cross-clamping for coronary artery bypass grafting may cause subendocardial injury. We investigated the use of lidocaine to prevent ventricular fibrillation during this period. In a blind, prospective, randomized trial, 91 consecutive patients undergoing elective coronary artery bypass graft procedures were given lidocaine (2 mg/kg) or normal saline immediately before removal of the aortic cross-clamp. The groups were similar with respect to demographic, clinical, and intraoperative variables. Myocardial preservation techniques were similar in both groups. Of 47 patients receiving lidocaine, 38 recovered a supraventricular rhythm without ventricular fibrillation, compared with only 5 of 44 patients in the control group (p < .001). When ventricular fibrillation occurred, patients in the control group required a greater number of direct-current countershocks (2.31 versus 1.86) to convert to sinus rhythm. Transient heart block, requiring temporary pacing, developed in 3 patients in the lidocaine group, compared with 1 patient in the control group. There was no significant difference between the groups in the requirement for perioperative inotropic support (6 of 47 versus 6 of 44) or the number of myocardial infarctions (2 of 47 versus 1 of 44), and there were no deaths in either group. Lidocaine infusion immediately before removal of the aortic cross-clamp significantly reduces the incidence of ventricular fibrillation during the reperfusion period after cardiopulmonary bypass.
This article has been cited by other articles:
![]() |
E. Ovrum, G. Tangen, E. Am Holen, M.-A. L. Ringdal, and R. Istad Conversion of postischemic ventricular fibrillation with intraaortic infusion of potassium chloride Ann. Thorac. Surg., July 1, 1995; 60(1): 156 - 159. [Abstract] [PDF] |
||||
![]() |
A. Baraka, N. Hirt, A. Dabbous, S. Taha, C. Rouhana, N. El-Khoury, M. Ghabash, M. Jamhoury, and A. Sibaii Lidocaine cardioplegia for prevention of reperfusion ventricular fibrillation Ann. Thorac. Surg., June 1, 1993; 55(6): 1529 - 1533. [Abstract] [PDF] |
||||
![]() |
R. L. Beaudet Ventricular fibrillation after myocardial revascularization Ann. Thorac. Surg., April 1, 1988; 45(4): 466 - 466. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |